enVVeno Medical Corp reports results for the quarter ended in September - Earnings Summary

enVVeno Medical

26/10/2023 13:01

* enVVeno Medical Corp  NVNO.OQ  reported a quarterly
adjusted
loss of 45 cents​​ per share for the quarter ended in September.
The lone analyst forecast for the quarter was for a loss of 48
cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * enVVeno Medical Corp's reported EPS for the quarter was a
loss
of 45 cents​.
    * The mean earnings estimate of analysts had risen by
about 5.9%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates 
    * enVVeno Medical Corp shares had fallen by 2.0% this
quarter and
gained 3.5% so far this year.
    * The company reported a quarterly loss of $5 million.
    * Wall Street's median 12-month price target for enVVeno
Medical
Corp is $20.40 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 1 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
October 26 at 12:01 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2023      -0.48          -0.45          Beat
 Jun. 30 2023      -0.49          -0.58          Missed
 Mar. 31 2023      -0.48          -0.57          Missed
 Dec. 31 2022      -0.57          -0.55          Beat